These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4156797)

  • 1. Antipsychotic drugs and catecholamine synapses. Summary of the session.
    Andén NE
    J Psychiatr Res; 1974; 11():97-104. PubMed ID: 4156797
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic drugs and catecholamine synapses.
    Carlsson A
    J Psychiatr Res; 1974; 11():57-64. PubMed ID: 4156791
    [No Abstract]   [Full Text] [Related]  

  • 3. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A
    Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of dopaminergic antagonists in the striatum.
    Sedvall G; Fyrö B; Nybäck H; Wiesel FA
    Adv Neurol; 1975; 9():131-40. PubMed ID: 238375
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
    Scatton B; Boireau A; Garret C; Glowinski J; Julou L
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of brain catecholamines in the regulation of ACTH secretion.
    Van Loon GR
    Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional role and pharmacological regulation of the dopaminergic system of the brain].
    Raevskiĭ KS
    Vestn Ross Akad Med Nauk; 1998; (8):19-24. PubMed ID: 9771125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychoactive drugs and brain neurochemical transmitters.
    Valzelli L
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:221+. PubMed ID: 4342945
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
    Elliott PN; Jenner P; Chadwick D; Reynolds E; Marsden CD
    J Pharm Pharmacol; 1977 Jan; 29(1):41-3. PubMed ID: 13181
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
    Matthysse S
    Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
    [No Abstract]   [Full Text] [Related]  

  • 13. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthyroidism: specifically increased response to central NA-(alpha-)receptor stimulation and generally increased monoamine turnover in brain.
    Strömbom U; Svensson TH; Jackson DM; Engström G
    J Neural Transm; 1977; 41(1):73-92. PubMed ID: 915501
    [No Abstract]   [Full Text] [Related]  

  • 15. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine receptors in the brain.
    Iversen LL
    Science; 1975 Jun; 188(4193):1084-9. PubMed ID: 2976
    [No Abstract]   [Full Text] [Related]  

  • 17. The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.
    Nemeroff CB
    Psychoneuroendocrinology; 1986; 11(1):15-37. PubMed ID: 2871577
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of motor activity in relation to monoaminergic mechanisms].
    Poirier LJ; Larochelle L; Bédard P; Parent A
    Rev Can Biol; 1972; 31():Suppl:175-80. PubMed ID: 4403290
    [No Abstract]   [Full Text] [Related]  

  • 19. The dopamine hypothesis of schizophrenia: a review.
    Meltzer HY; Stahl SM
    Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.